According to Immunovant's latest financial reports the company's current EPS (TTM) is -$2.62. In 2022 the company made an earnings per share (EPS) of -$2.25 a decrease over its 2021 EPS that were of -$1.76.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$2.63 | 16.67% |
2022 | -$2.25 | 27.69% |
2021 | -$1.76 | -2.26% |
2020 | -$1.80 | 668.98% |
2019 | -$0.23 |